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Introduction
The progressive increase of shoulder arthroplasty implants is correlated to a major incidence of peri-prosthetic fractures. The frequency of these traumatic events on shoulder is 0.6-3% and 40% of these cases are represented by low-energy post-operative fractures [1] . Treatment varies from conservative to implant revision and depends on the type of fracture and the stability of prosthesis [2, 3] . If not completely treated, peri-prosthetic fractures may lead to non-union.
Presentation of case
We report a case of a 64-years-old woman with a complete right upper limb dysfunction (DASH 32) [8] due to non-union (type B2 according to Worland classification) [4] occurred on a periprosthetic fracture at the distal end of the humeral stem of RSA (reverse shoulder arthroplasty), positioned 3 years before.
Immobilization with an arm brace was used as first conservative treatment.
The following x-ray evaluations showed a progression from fracture to non-union and a varus angle deformity (Fig. 1) .
In order to definitively correct such deformity we chose surgical treatment. We removed fibrous tissue around the locus, reduced the fracture and performed osteo-synthesis with plate, screws and wires in addition to a massive bone autograft. At first a 15 cm autologous bone from peroneal diaphysis and a 8 cm piece of cortical bone from iliac crest were harvested. Then the fracture line was exposed and the surface was regularized, scratched and freshened (Fig. 2) . Finally, we corrected the skeletal deformity and defect performing an osteo-synthesis of the fracture line using the autologous bone and a straight plate that was fixed distally with 3 screws, proximally with 4 screws and with 3 looping wires [5, 6] (Fig. 3) . Postoperatively, the patient followed a therapy with Teriparatide (20 g/die for 3 months) [7, 8] . X-ray control was performed at 3 months. Teriparatide is the foreshortened amino terminal peptide of PTH and has a osteoanabolic effect when administered once daily in low doses for the treatment of osteoporosis. There is evidence that Teriparatide also accelerates the fracture healing process by improving the biomechanical properties of the fracture callus, increasing endochondral ossification and bone remodelling in animal models [9] .
The control X ray at 1 year postoperatively showed a complete fracture healing (Fig. 4) . Clinical control was good (DASH Score 76) [10] .
Discussion
Multiple factors can contribute to fracture non-union. Humeral diaphysial fracture is always unstable and requires surgical approach. Non-union may occur after surgical treatment when a good reduction of the fracture or a stable fixation is not achieved. Systemic environment can be another cause of bone healing failure and non-union, but it is essential to respect biomechanical principles to reduce failure percentage.
The application of bone autografts offers an additional guarantee to "revitalize" non-union locus. Actually bone substitutes [11] , scaffolds, bone marrow, platelet rich plasma [12] and mesenchymal stem cells represent a supplementary resource for efficacious treatment. In this case, we tried to achieve the best solution in mechanical stability (plate, screws and wires) and we combined a supportive treatment to osteogenic processes (autologous bone grafts and therapy with Teriparatide) [13] . Our method follows the Giannoudis' "Diamond concept" about fracture healing [14] .
Conclusions
Both biology and mechanics are essential for a successfully fracture healing process. These two factors have to blend together in order to lead to proliferative and differentiative cell processes. In the examined case, the correct reduction and osteo-synthesis of the fracture combined with Teriparatide therapy showed good clinical result.
This case report has been reported in line with the SCARE criteria [15] .
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